These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31727469)

  • 1. Design, synthesis and biological evaluation of suramin-derived dual antagonists of the proinflammatory G protein-coupled receptors P2Y
    Pillaiyar T; Funke M; Al-Hroub H; Weyler S; Ivanova S; Schlegel J; Abdelrahman A; Müller CE
    Eur J Med Chem; 2020 Jan; 186():111789. PubMed ID: 31727469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling of a suramin-derived compound library at recombinant human P2Y receptors identifies NF272 as a competitive but non-selective P2Y
    Brockmann N; Sureechatchaiyan P; Müller D; Hennicke T; Hausmann R; Fritz G; Hamacher A; Kassack MU
    Purinergic Signal; 2019 Sep; 15(3):287-298. PubMed ID: 31270713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand binding and activation of UTP-activated G protein-coupled P2Y
    Attah IY; Neumann A; Al-Hroub H; Rafehi M; Baqi Y; Namasivayam V; Müller CE
    Biochim Biophys Acta Gen Subj; 2020 Mar; 1864(3):129501. PubMed ID: 31812541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPR17: molecular modeling and dynamics studies of the 3-D structure and purinergic ligand binding features in comparison with P2Y receptors.
    Parravicini C; Ranghino G; Abbracchio MP; Fantucci P
    BMC Bioinformatics; 2008 Jun; 9():263. PubMed ID: 18533035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From UTP to AR-C118925, the discovery of a potent non nucleotide antagonist of the P2Y
    Kindon N; Davis A; Dougall I; Dixon J; Johnson T; Walters I; Thom S; McKechnie K; Meghani P; Stocks MJ
    Bioorg Med Chem Lett; 2017 Nov; 27(21):4849-4853. PubMed ID: 28958619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of the P2Y2 Receptor Attenuates Alcoholic Liver Inflammation by Targeting the EGFR-ERK1/2 Signaling Pathway.
    Liu ZN; Su QQ; Wang YH; Wu X; Lv XW
    Drug Des Devel Ther; 2022; 16():1107-1120. PubMed ID: 35444406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor.
    Ciana P; Fumagalli M; Trincavelli ML; Verderio C; Rosa P; Lecca D; Ferrario S; Parravicini C; Capra V; Gelosa P; Guerrini U; Belcredito S; Cimino M; Sironi L; Tremoli E; Rovati GE; Martini C; Abbracchio MP
    EMBO J; 2006 Oct; 25(19):4615-27. PubMed ID: 16990797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing HAMI3379 to Block GPR17 and Promote Rodent and Human Oligodendrocyte Differentiation.
    Merten N; Fischer J; Simon K; Zhang L; Schröder R; Peters L; Letombe AG; Hennen S; Schrage R; Bödefeld T; Vermeiren C; Gillard M; Mohr K; Lu QR; Brüstle O; Gomeza J; Kostenis E
    Cell Chem Biol; 2018 Jun; 25(6):775-786.e5. PubMed ID: 29706593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of imidazothiazinones and analogs as antagonists of the cannabinoid-activated orphan G protein-coupled receptor GPR18.
    Schoeder CT; Kaleta M; Mahardhika AB; Olejarz-Maciej A; Łażewska D; Kieć-Kononowicz K; Müller CE
    Eur J Med Chem; 2018 Jul; 155():381-397. PubMed ID: 29902723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Close association of B2 bradykinin receptors with P2Y2 ATP receptors.
    Yashima S; Shimazaki A; Mitoma J; Nakagawa T; Abe M; Yamada H; Higashi H
    J Biochem; 2015 Aug; 158(2):155-63. PubMed ID: 25713410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-activity relationships of suramin-derived P2Y11 receptor antagonists with nanomolar potency.
    Ullmann H; Meis S; Hongwiset D; Marzian C; Wiese M; Nickel P; Communi D; Boeynaems JM; Wolf C; Hausmann R; Schmalzing G; Kassack MU
    J Med Chem; 2005 Nov; 48(22):7040-8. PubMed ID: 16250663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decoding signaling and function of the orphan G protein-coupled receptor GPR17 with a small-molecule agonist.
    Hennen S; Wang H; Peters L; Merten N; Simon K; Spinrath A; Blättermann S; Akkari R; Schrage R; Schröder R; Schulz D; Vermeiren C; Zimmermann K; Kehraus S; Drewke C; Pfeifer A; König GM; Mohr K; Gillard M; Müller CE; Lu QR; Gomeza J; Kostenis E
    Sci Signal; 2013 Oct; 6(298):ra93. PubMed ID: 24150254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Orphan Receptor GPR17 Is Unresponsive to Uracil Nucleotides and Cysteinyl Leukotrienes.
    Simon K; Merten N; Schröder R; Hennen S; Preis P; Schmitt NK; Peters L; Schrage R; Vermeiren C; Gillard M; Mohr K; Gomeza J; Kostenis E
    Mol Pharmacol; 2017 May; 91(5):518-532. PubMed ID: 28254957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current knowledge on the nucleotide agonists for the P2Y2 receptor.
    Xu P; Feng X; Luan H; Wang J; Ge R; Li Z; Bian J
    Bioorg Med Chem; 2018 Jan; 26(2):366-375. PubMed ID: 29254895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is GPR17 a P2Y/leukotriene receptor? examination of uracil nucleotides, nucleotide sugars, and cysteinyl leukotrienes as agonists of GPR17.
    Qi AD; Harden TK; Nicholas RA
    J Pharmacol Exp Ther; 2013 Oct; 347(1):38-46. PubMed ID: 23908386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of membrane raft recruitment of the bradykinin B2 receptor by close association with the ATP/UTP receptor P2Y
    Nakagawa T; Takahashi C; Matsuzaki H; Kuroda Y; Higashi H
    Biochem Biophys Res Commun; 2018 Oct; 505(1):36-39. PubMed ID: 30236981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, characterization, and in vitro evaluation of the selective P2Y
    Rafehi M; Burbiel JC; Attah IY; Abdelrahman A; Müller CE
    Purinergic Signal; 2017 Mar; 13(1):89-103. PubMed ID: 27766552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of PC12 cell survival and differentiation by the new P2Y-like receptor GPR17.
    Daniele S; Lecca D; Trincavelli ML; Ciampi O; Abbracchio MP; Martini C
    Cell Signal; 2010 Apr; 22(4):697-706. PubMed ID: 20056144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonist-induced desensitization/resensitization of human G protein-coupled receptor 17: a functional cross-talk between purinergic and cysteinyl-leukotriene ligands.
    Daniele S; Trincavelli ML; Gabelloni P; Lecca D; Rosa P; Abbracchio MP; Martini C
    J Pharmacol Exp Ther; 2011 Aug; 338(2):559-67. PubMed ID: 21531793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2Y
    De Oliveira Moreira D; Santo Neto H; Marques MJ
    Muscle Nerve; 2017 Jan; 55(1):116-121. PubMed ID: 27220808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.